CRISPR: three new developments in the world of gene editing

In this article, we outline three recent studies that have advanced the potential uses of CRISPR in the biomedical field.

A new variant for CRISPR

In a new study, researchers from Michigan Medicine at the University of Michigan, US, revealed that using a novel variant to repair DNA can improve both safety and effectiveness of CRISPR-Cas9 for genetic research.

According to the scientists, the safety and efficacy of CRISPR-Cas9 are what continue to hold the gene editing technique back from its full clinical potential.

To develop their variant, the researchers fused a minimal motif consisting of 36 amino acids to a gene-editing nuclease Streptococcus pyogenes Cas9 (spCas9). According to the team, the new meticulous integration Cas9 (miCas9) binds RAD51 through this fusion motif and enriches RAD51 at the target locus.

Cancer du poumon: espoir d'une immunothérapie plus efficace

Biomarker weist frühzeitig auf schwere COVID-19-Verläufe hin

CAR-T-Zell-Therapie hilft bei schwerem Lupus erythematodes

Vermehrung des Coronavirus lässt sich mit Crispr-Methode stoppen

Hoffnung auf Heilung

COVID-19-Test weist Antikörper in winzigen BlutProben nach